All Stories

  1. An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation
  2. Patent foramen oval and ESUS in cryptogenic stroke: still a complex puzzle
  3. Multimodality Imaging in Right Heart Tumors: Proposed Algorithm towards an Appropriate Diagnosis
  4. Updated Strategies in Non-Culprit Stenosis Management of Multivessel Coronary Disease—A Contemporary Review
  5. Patent foramen oval and ESUS in cryptogenic stroke: Still a complex puzzle
  6. Left atrial autonomic remodeling and ganglionated plexi
  7. Depiction of Branched-Chain Amino Acids (BCAAs) in Diabetes with a Focus on Diabetic Microvascular Complications
  8. Subclinical systolic dysfunction and myocardial deformation: From GLS to VVI
  9. Effects of Incretin-Based Treatment on the Diastolic (Dys)Function in Patients with Uncontrolled Type 2 Diabetes Mellitus: A Prospective Study with 1-Year Follow-Up
  10. Pulmonary pulse transit time as the first sign of pulmonary arterial hemodynamics alteration
  11. Efficacy and Safety of Ticagrelor versus Clopidogrel in Dialysis Patients with Coronary Syndromes: A Systematic Review and Meta-Analysis
  12. Mitral Annular Calcification and Thromboembolic Risk
  13. Atrial Fibrillation and Chronic Coronary Ischemia: A Challenging Vicious Circle
  14. Portrayal of NLRP3 Inflammasome in Atherosclerosis: Current Knowledge and Therapeutic Targets
  15. Gastro-Esophageal Reflux Disease and Paroxysmal Atrial Fibrillation Ablation
  16. Prognosis in cardiac amyloidosis: Data from three‐dimensional speckle‐tracking echocardiography
  17. Bradyarrhythmias in patients with atrial fibrillation
  18. Myocardial work and permissive cardiotoxicity – A proactive approach in cardio‐oncology
  19. Nontrombotic Pulmonary Embolism: Different Etiology, Same Significant Consequences
  20. The Oral Microbiota in Valvular Heart Disease: Current Knowledge and Future Directions
  21. Multimodality imaging approach of patent foramen ovale: Practical considerations for transient ischemic attack/stroke
  22. Association of Inflammatory and Metabolic Biomarkers with Mitral Annular Calcification in Type 2 Diabetes Patients
  23. Oxidative Stress and NRF2/KEAP1/ARE Pathway in Diabetic Kidney Disease (DKD): New Perspectives
  24. Contribution of Oxidative Stress (OS) in Calcific Aortic Valve Disease (CAVD): From Pathophysiology to Therapeutic Targets
  25. Predicting Renal Denervation Response in Resistant High Blood Pressure by Arterial Stiffness Assessment: A Systematic Review
  26. Pepsin and the Lung—Exploring the Relationship between Micro-Aspiration and Respiratory Manifestations of Gastroesophageal Reflux Disease
  27. Subclinical target organ damage as risk stratification parameter in hypertensive patients
  28. Hereditary Hemorrhagic Telangiectasia and Arterio-Venous Malformations—From Diagnosis to Therapeutic Challenges
  29. The Usefulness of Assessing Heart Rate Variability in Patients with Acute Myocardial Infarction (HeaRt-V-AMI)
  30. Left atrial functional changes as emerging diagnostic and prognostic marker
  31. Pulmonary Arterial Hypertension and Adverse Outcomes after Kidney Transplantation: A Systematic Review and Meta-Analysis
  32. Current Therapeutic Approach to Atrial Fibrillation in Patients with Congenital Hemophilia
  33. Oxidative Stress in Arterial Hypertension (HTN): The Nuclear Factor Erythroid Factor 2-Related Factor 2 (Nrf2) Pathway, Implications and Future Perspectives
  34. The Prognostic Performance of Ferritin in Patients with Acute Myocardial Infarction: A Systematic Review
  35. Involvement of Ceramides in Non-Alcoholic Fatty Liver Disease (NAFLD) Atherosclerosis (ATS) Development: Mechanisms and Therapeutic Targets
  36. Current Knowledge of MicroRNAs (miRNAs) in Acute Coronary Syndrome (ACS): ST-Elevation Myocardial Infarction (STEMI)
  37. Anemia in Crohn’s Disease—The Unseen Face of Inflammatory Bowel Disease
  38. Measuring Heart Rate Variability in Patients Admitted with ST-Elevation Myocardial Infarction for the Prediction of Subsequent Cardiovascular Events: A Systematic Review
  39. Hyponatremia—Long-Term Prognostic Factor for Nonfatal Pulmonary Embolism
  40. Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM)
  41. Ventricular arrhythmic risk prediction: simpler is easier
  42. Hypothyroidism-Induced Nonalcoholic Fatty Liver Disease (HIN): Mechanisms and Emerging Therapeutic Options
  43. The Intricate Relationship between Type 2 Diabetes Mellitus (T2DM), Insulin Resistance (IR), and Nonalcoholic Fatty Liver Disease (NAFLD)
  44. Left Atrial Structural Remodelling in Non-Valvular Atrial Fibrillation: What Have We Learnt from CMR?
  45. The Predictive Role of the Biomarker Kidney Molecule-1 (KIM-1) in Acute Kidney Injury (AKI) Cisplatin-Induced Nephrotoxicity
  46. Clinical and Biological Profile of Patients with Non-Valvular Atrial Fibrillation and Hemodynamic Significant Valvular Heart Disease
  47. Left Ventricular Diastolic Dysfunction in Type 2 Diabetes—Progress and Perspectives
  48. The use of mannitol in neurosurgery and neuro-ophthalmology
  49. Characteristics of shared decision making in Romania from the patient perspective: A cross‐sectional multicentric study
  50. The Influence of Cardiovascular Medications on Iron Metabolism in Patients with Heart Failure
  51. Romanian version of SDM-Q-9 validation in Internal Medicine and Cardiology setting: a multicentric cross-sectional study
  52. Atrial fibrillation type and renal dysfunction: new challenges in thromboembolic risk assessment
  53. Natriuretic Peptides in Heart Failure with Preserved Left Ventricular Ejection Fraction: From Molecular Evidences to Clinical Implications
  54. Arterial Hypertension and Interleukins: Potential Therapeutic Target or Future Diagnostic Marker?
  55. Glomerular Filtration Rate as Prognostic Marker in Acute Pulmonary Embolism
  56. The SCORE model and cardiovascular risk assessment — between utility and limits. Commentary to the article: “Association between carotid-femoral pulse wave velocity and overall cardiovascular risk score assessed by the SCORE system in urban Polish popu...
  57. The Mediterranean Diet: From an Environment-Driven Food Culture to an Emerging Medical Prescription
  58. Cardiovascular Manifestations of Inflammatory Bowel Disease: Pathogenesis, Diagnosis, and Preventive Strategies
  59. SUCCESS score for success rate in atrial fibrillation ablation: one size fits all?
  60. Pancreatico-Pleural Fistula – from Diagnosis to Management. A Case Report
  61. Implications of the Intestinal Microbiota in Diagnosing the Progression of Diabetes and the Presence of Cardiovascular Complications
  62. The Role of Combining Biochemical Markers in Assessing the Endoscopic Activity in Ulcerative Colitis
  63. A Rare Cause of Supraventricular Ectopic Beats and Angina in a Young Patient
  64. Anemia in heart failure - from guidelines to controversies and challenges
  65. Postoperative atrial fibrillation prediction following isolated surgical aortic valve replacement
  66. Incidence of left atrial thrombus prior to catheter ablation of atrial fibrillation: Is it time for atrial cardiomyopathy evaluation?
  67. Abnormal standard biochemical values are associated with the presence of subclinical atherosclerosis in asymptomatic population
  68. Telemedicine: Good or bad and for whom?
  69. Subclinical cardiovascular disease assessment and its relationship with cardiovascular risk SCORE in a healthy adult population: A cross-sectional community-based study
  70. Atrial fibrillation and sympathovagal balance in patients with gastroesophageal reflux disease
  71. Ganglionated plexi interactions with atrio-ventricular node and right vagus nerve
  72. Ganglionated plexi interactions with atrio-ventricular node and right vagus nerve
  73. Multimodality Echocardiographic Assessment of Patients Undergoing Atrial Fibrillation Ablation
  74. Coronary sinus thrombus without spontaneous contrast
  75. Mitral annular calcification: left atrial size and left ventricular dysfunction
  76. Myocardial strain imaging and malignant ventricular arrhythmia risk
  77. Non-alcoholic fatty liver disease–From the cardiologist perspective
  78. Chronic kidney disease: Prognostic marker of nonfatal pulmonary thromboembolism
  79. QT interval variations and mortality risk: Is there any relationship?
  80. Atrial fibrillation and gastroesophageal reflux disease: From the cardiologist perspective
  81. Double papillary fibroelastoma: Beautiful, innocent flowers in the left heart
  82. Complication due to entrapment in the Chiari apparatus
  83. Early Repolarization Syndrome: Electrocardiographic Signs and Clinical Implications
  84. Transesophageal Echocardiography Before Pulmonary Vein Isolation in Nonvalvular Atrial Fibrillation: A Tentative for Better Evaluation
  85. Excluding the Presence of Left Atrial Thrombus Before Pulmonary Vein Isolation
  86. Aberrantly inserted chordae tendineae without significant mitral regurgitation
  87. Predictive Value of Thromboembolic Risk Scores Before an Atrial Fibrillation Ablation Procedure
  88. Stroke and an unexplained dyspnea in an elderly patient: Platypnea‐orthodeoxia syndrome
  89. A rare primary cardiac tumour: cavernous hemangioma of the tricuspid valve
  90. Author`s reply
  91. Abnormal Atrioventricular Node Conduction and Atrioventricular Nodal Reentrant Tachycardia in Patients Older Versus Younger Than 65 Years of Age
  92. Assessment of left atrial shape and volume in structural remodeling secondary to atrial fibrillation
  93. Variable morphologies of preexcitation due to a concomitant Brugada pattern